軸向改性卟啉在光動(dòng)力治療的研究
[Abstract]:Photodynamic therapy (PDT) is different from traditional methods in the treatment of tumor. Its basic principle is that after the tumor patients are injected with Guang Min, the drug can be targeted around the tumor tissue and be exposed to light at a certain wavelength. The drug of Guang Min stimulates the action of oxygen around the tumor tissue after absorbing the light energy and produces the highly active singlet oxygen which eventually induces the death of tumor cells and achieves the purpose of treating tumor. The application of Guang Min in PDT is limited due to its poor tumor targeting and easy aggregation among molecules. In order to solve these problems, the axial and biologically targeted tin porphyrin (Guang Min) agents have been studied in this paper. In this paper, tetraphenylporphyrin was prepared by Adler method. The tetraphenyltin porphyrin Sn Cl2 2H2O was prepared by pyridine method and then grafted with malonic acid and acetylated glucosamine. Tetra (4-sulfophenyl) porphyrin was obtained by sulfonation of tetraphenylporphyrins with concentrated H2SO4 as sulfonation agent. Metalloporphyrins were synthesized by methanol method, and tetra-( 4-sulfophenyl) tin porphyrin-hyaluronic acid was grafted onto hyaluronic acid to obtain tetra- (4-sulfophenyl) tin porphyrin-hyaluronic acid. The structures of these two kinds of porphyrins were characterized by 1H NMR), UV-Vis (UV-Vis) and IR (FT-IR) spectra. Finally, the single-line oxygen yields of two kinds of substances were determined by using 1 ~ 3- diphenyl isobenzofuran (DPBF) as the trapping agent of singlet oxygen. The results show that the two porphyrin Guang Min agents can produce higher singlet oxygen with the yields of 0.68 and 0.73, respectively. The results show that axial coordination can effectively solve the self-polymerization of porphyrin molecules and ensure the yield of singlet oxygen. Therefore, it has potential application value in biomedical field.
【學(xué)位授予單位】:長(zhǎng)春理工大學(xué)
【學(xué)位級(jí)別】:碩士
【學(xué)位授予年份】:2017
【分類號(hào)】:R943
【參考文獻(xiàn)】
相關(guān)期刊論文 前10條
1 李黎波;李文敏;項(xiàng)蕾紅;秦中平;王洛偉;林盡染;馬英;羅榮城;黃正;;光動(dòng)力療法在中國(guó)的應(yīng)用與臨床研究[J];中國(guó)激光醫(yī)學(xué)雜志;2012年05期
2 章忠強(qiáng);姚宏亮;文宇;苗雄鷹;熊力;;光動(dòng)力技術(shù)治療胃癌的進(jìn)展及展望[J];激光生物學(xué)報(bào);2012年04期
3 潘向榮;陳小勛;;腫瘤化療不良反應(yīng)的中醫(yī)藥治療近況[J];醫(yī)學(xué)綜述;2010年15期
4 顧健人;曹雪濤;;癌癥治療存在的問題以及生物治療面臨的機(jī)遇與挑戰(zhàn)[J];中國(guó)腫瘤生物治療雜志;2008年01期
5 朱湛;張青山;郭炳南;梁棟;;N,N′-二茂鐵二甲酰氨基葡萄糖的合成[J];精細(xì)化工;2007年08期
6 劉凡光,李曉松;光動(dòng)力學(xué)療法在中國(guó)[J];中國(guó)激光醫(yī)學(xué)雜志;2005年01期
7 馬小琴,賀同慶,鄭濤,徐冰心,肖成榮,鄭思新,林曉榮,高沛永,申戈,鮑云華,高紅軍,楊武威;地爾硫防治腫瘤病人放療不良反應(yīng)的臨床研究[J];中國(guó)藥學(xué)雜志;2004年03期
8 喬巖,王麗,王愛勤;D-氨基葡萄糖的化學(xué)修飾及其在生物醫(yī)藥領(lǐng)域的應(yīng)用[J];中國(guó)海洋藥物;2003年06期
9 周傳農(nóng);國(guó)外光動(dòng)力療法新進(jìn)展——國(guó)際光動(dòng)力學(xué)會(huì)第九屆年會(huì)簡(jiǎn)介[J];中國(guó)激光醫(yī)學(xué)雜志;2003年04期
10 李運(yùn)曼,唐明月,夏雯,李特;D-氨基葡萄糖鹽酸鹽的抗腫瘤作用[J];中國(guó)天然藥物;2003年04期
,本文編號(hào):2179676
本文鏈接:http://sikaile.net/yixuelunwen/yiyaoxuelunwen/2179676.html